Position in VERA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$135,319,156
-$223,868 QoQ
Shares Held
3,363,638
+25.7% QoQ
Ownership
4.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 10.139051824245058.ToString("F0")%
Shared 0.ToString("F0")%
None 89.86094817575494.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. VERA ranks #50 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in VERA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $135,319,156 | 3,363,638 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $135,543,024 | 2,676,600 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $67,813,921 | 2,333,583 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $47,536,611 | 2,017,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $50,034,812 | 2,083,048 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $85,694,426 | 2,026,352 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $80,612,269 | 1,823,807 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $77,987,907 | 2,155,553 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $101,363,348 | 2,350,727 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $33,544,672 | 2,181,058 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,686,026 | 1,727,646 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,253,611 | 576,549 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,360,180 | 304,147 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,967,067 | 256,696 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $5,322,875 | 249,783 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,024,890 | 222,255 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,964,101 | 168,757 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,293,854 | 123,273 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,305,674 | 75,255 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||